Información de la droga para Wyeth Antivenin (Micrurus fulvius) (Equine Origin) North American Coral Snake Antivenin (Wyeth Pharmaceuticals Company): REFERENCES

Ads
    • MC COLLOUGH, N. and GENNARO, J.: Coral snakebites in the United States. J. Florida Med. Assn. 49:968, 1963.
    • FIX, J. and MINTON, S.: Venom extraction and yields from the North American Coral Snake, Micrurus fulvius. Toxicon 14:143, 1976.
    • PARRISH, H. and KAHN, M.: Bites by coral snakes: Report of 11 representative cases. Am. J. Med. Sci. 253:561, 1967.
    • MOSELY, T.: Coral snakebite: Recovery following symptoms of respiratory paralysis. Ann. Surg. 163:943, 1966.
    • RAMSEY, G. and KLICKSTEIN, G.: Coral snakebite. Report of a case and suggested therapy. JAMA 182:949, 1962.
    • NEILL, W.: Some misconceptions regarding the eastern coral snake, Micrurus fulvius. Herpetologica 13:111, 1957.
    • RUSSELL, F.: Bites by the Sonoran coral snake, Micruroides euryxanthus. Toxicon 5:39, 1967.
    • WINGERT, W. and WAINSCHEL, J.: Diagnosis and management of envenomation by poisonous snakes. South. Med. J. 68:1015, 1975.
    • RUSSEL, F.: Snake venom poisoning. Scholium International, Inc., New York, 1983.
    • LOPRINZI, C. et al: Snake Antivenin administration in a patient allergic to horse serum. South. Med. J. 76:501, 1983.
    • OTTEN, E. & MCKIMM, D.: Venomous snakebite in a patient allergic to horse serum. Ann. Emerg. Med. 12:624, 1983.
    • BOWDEN, C. & KRENZELOK, E.: Clinical applications of commonly used contemporary antidotes, a US perspective. Drug Safety 16(1):22-24, 1997.
    • Wyeth-Ayerst Data on File.
    • JURKOVICH, G. et al: Complications of Crotalidae Antivenin therapy. The J. of Trauma 28:7, 1988.
    • TOOGOOD, J.: Beta-blocker therapy and the risk of anaphylaxis. Canc. Med. Assoc. J. 136:929, 1987.
    • LAWRENCE, W. et al: Pitviper bites: Rational management in which Copperheads and Cottonmouths predominate. Annals of Plastic Surg. 36(3):276, 1996.

    U.S. Govt. License No. 3

    Wyeth Laboratories Inc., Marietta, PA 17547

    CI3280-4

    ET01

    Revised August 31, 2001

  • Drug Information Provided by National Library of Medicine (NLM).
Ads